ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 95 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $70,927 | -18.0% | 27,175 | +12.4% | 0.00% | – |
Q2 2023 | $86,547 | +64.2% | 24,175 | 0.0% | 0.00% | – |
Q1 2023 | $52,702 | -80.2% | 24,175 | +9.0% | 0.00% | – |
Q4 2022 | $266,765 | +94.7% | 22,175 | +4.6% | 0.00% | – |
Q3 2022 | $137,000 | +41.2% | 21,200 | 0.0% | 0.00% | – |
Q2 2022 | $97,000 | -47.0% | 21,200 | 0.0% | 0.00% | – |
Q1 2022 | $183,000 | -39.6% | 21,200 | 0.0% | 0.00% | – |
Q4 2021 | $303,000 | -35.0% | 21,200 | 0.0% | 0.00% | – |
Q3 2021 | $466,000 | +64.1% | 21,200 | 0.0% | 0.00% | – |
Q2 2021 | $284,000 | +32.1% | 21,200 | 0.0% | 0.00% | – |
Q1 2021 | $215,000 | +138.9% | 21,200 | 0.0% | 0.00% | – |
Q4 2020 | $90,000 | +63.6% | 21,200 | 0.0% | 0.00% | – |
Q3 2020 | $55,000 | -26.7% | 21,200 | 0.0% | 0.00% | – |
Q2 2020 | $75,000 | +17.2% | 21,200 | 0.0% | 0.00% | – |
Q1 2020 | $64,000 | -41.3% | 21,200 | 0.0% | 0.00% | – |
Q4 2019 | $109,000 | +60.3% | 21,200 | 0.0% | 0.00% | – |
Q3 2019 | $68,000 | -10.5% | 21,200 | 0.0% | 0.00% | – |
Q2 2019 | $76,000 | -1.3% | 21,200 | 0.0% | 0.00% | – |
Q1 2019 | $77,000 | +20.3% | 21,200 | 0.0% | 0.00% | – |
Q4 2018 | $64,000 | -37.9% | 21,200 | 0.0% | 0.00% | – |
Q3 2018 | $103,000 | -34.8% | 21,200 | 0.0% | 0.00% | – |
Q2 2018 | $158,000 | +14.5% | 21,200 | 0.0% | 0.00% | – |
Q1 2018 | $138,000 | -27.7% | 21,200 | 0.0% | 0.00% | – |
Q4 2017 | $191,000 | -9.5% | 21,200 | 0.0% | 0.00% | – |
Q3 2017 | $211,000 | +27.9% | 21,200 | 0.0% | 0.00% | – |
Q2 2017 | $165,000 | +26.9% | 21,200 | 0.0% | 0.00% | – |
Q1 2017 | $130,000 | 0.0% | 21,200 | 0.0% | 0.00% | – |
Q4 2016 | $130,000 | -15.6% | 21,200 | 0.0% | 0.00% | – |
Q3 2016 | $154,000 | +33.9% | 21,200 | +53.5% | 0.00% | – |
Q2 2016 | $115,000 | +25.0% | 13,807 | 0.0% | 0.00% | – |
Q1 2016 | $92,000 | +300.0% | 13,807 | +408.0% | 0.00% | – |
Q4 2015 | $23,000 | +53.3% | 2,718 | 0.0% | 0.00% | – |
Q3 2015 | $15,000 | 0.0% | 2,718 | 0.0% | 0.00% | – |
Q2 2015 | $15,000 | – | 2,718 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Acrospire Investment Management LLC | 8,355 | $61,000 | 0.04% |
TOCQUEVILLE ASSET MANAGEMENT L.P. | 70,000 | $508,000 | 0.01% |
Financial Architects, Inc | 2,000 | $15,000 | 0.00% |
FineMark National Bank & Trust | 3,473 | $25,000 | 0.00% |
JFS WEALTH ADVISORS, LLC | 1,000 | $7,000 | 0.00% |
Penserra Capital Management LLC | 2,540 | $18,000 | 0.00% |
Tower Research Capital LLC (TRC) | 1,284 | $10,000 | 0.00% |
SIMPLEX TRADING, LLC | 2,673 | $19,000 | 0.00% |
Plante Moran Financial Advisors, LLC | 300 | $2,000 | 0.00% |
Cutler Group LLC / CA | 2,404 | $17,000 | 0.00% |